Pomalidomide | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Pomalidomide
US Exclusivities

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Pomalidomide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

28 API Suppliers, 14 USDMF, 7 EU WC, 6 KDMF, 10 NDC API, 20 Listed Suppliers, $ API Reference Price

28 API Suppliers
14 USDMF
7 EU WC
6 KDMF
10 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

22 Drugs in Development

22 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

129 FDF Dossiers, 32 FDA Orange Book, 16 Europe, 24 Canada, 36 Australia, 4 South Africa, 17 Listed Dossiers

129 FDF Dossiers
32 FDA Orange Book
16 Europe
24 Canada
36 Australia
4 South Africa
17 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 17 SPI Pharma, 2 Faran Shimi Pharmaceutical, 1 Chynops Pharma, 3 Gangwal Healthcare, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 1 Alcedo Pharmachem, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 2 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 3 Kerry, 2 Microlex e.U, 1 NEWEDGE Overseas, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Prachin Chemical, 8 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Minakem
1 Rochem International Inc
17 SPI Pharma
2 Faran Shimi Pharmaceutical
1 Chynops Pharma
3 Gangwal Healthcare
1 Pfanstiehl
1 Pramukh Pharmachem
1 Zeal MediPharma
1 Alcedo Pharmachem
2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
2 Gangwal Chemicals
3 Ingredion Pharma Solutions
3 Kerry
2 Microlex e.U
1 NEWEDGE Overseas
1 Pharmatrans-Sanaq
2 Pluviaendo
1 Prachin Chemical
8 Roquette
1 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

29 Fillers, Diluents & Binders, 15 Chewable & Orodispersible Aids, 14 Direct Compression, 13 Taste Masking, 12 Disintegrants & Superdisintegrants, 8 Co-Processed Excipients, 5 Lubricants & Glidants, 4 Parenteral, 4 Granulation, 3 Thickeners and Stabilizers, 2 Coating Systems & Additives, 1 Solubilizers, 1 Controlled & Modified Release

29 Fillers, Diluents & Binders
15 Chewable & Orodispersible Aids
14 Direct Compression
13 Taste Masking
12 Disintegrants & Superdisintegrants
8 Co-Processed Excipients
5 Lubricants & Glidants
4 Parenteral
4 Granulation
3 Thickeners and Stabilizers
2 Coating Systems & Additives
1 Solubilizers
1 Controlled & Modified Release

DIGITAL CONTENT

83 News #PharmaBuzz

83 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 12 Regulatory FDF Prices, 11 Annual Reports

1 US Medicaid Prescriptions
12 Regulatory FDF Prices
11 Annual Reports

MARKET PLACE

7 APIs, 1 FDF Dossiers

7 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

36 US Patents, 16 US Exclusivities, 8 Health Canada Patents

36 US Patents
16 US Exclusivities
8 Health Canada Patents

$ API Ref.Price (USD/KG) : 74,489 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

16 All

01 16BRISTOL

filter Product Reset all filters

16 All

01 16POMALIDOMIDE

filter Exclusivity Expiration Date Reset all filters

16 All

01 82027-05-14

02 82027-11-14

filter Exclusivity Code Reset all filters

16 All

01 4ODE-296

02 4ODE-297

03 8PED

Product Main Page

BRISTOL

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

POMALIDOMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-297

Exclusivity Expiration Date

2027-05-14

Application Number

204026

Product Number

2

Exclusivity Details

01

BRISTOL

Immuno-Oncology 360

Not Confirmed

BRISTOL

United Kingdom

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

POMALIDOMIDE

Exclusivity Code : ODE-297

Exclusivity Expiration Date : 2027-05-14

Application Number : 204026

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

POMALIDOMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-296

Exclusivity Expiration Date

2027-05-14

Application Number

204026

Product Number

1

Exclusivity Details

02

BRISTOL

Immuno-Oncology 360

Not Confirmed

BRISTOL

United Kingdom

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

POMALIDOMIDE

Exclusivity Code : ODE-296

Exclusivity Expiration Date : 2027-05-14

Application Number : 204026

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

POMALIDOMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2027-11-14

Application Number

204026

Product Number

1

Exclusivity Details

03

BRISTOL

Immuno-Oncology 360

Not Confirmed

BRISTOL

United Kingdom

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

POMALIDOMIDE

Exclusivity Code : PED

Exclusivity Expiration Date : 2027-11-14

Application Number : 204026

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

POMALIDOMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-297

Exclusivity Expiration Date

2027-05-14

Application Number

204026

Product Number

1

Exclusivity Details

04

BRISTOL

Immuno-Oncology 360

Not Confirmed

BRISTOL

United Kingdom

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

POMALIDOMIDE

Exclusivity Code : ODE-297

Exclusivity Expiration Date : 2027-05-14

Application Number : 204026

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

POMALIDOMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2027-11-14

Application Number

204026

Product Number

1

Exclusivity Details

05

BRISTOL

Immuno-Oncology 360

Not Confirmed

BRISTOL

United Kingdom

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

POMALIDOMIDE

Exclusivity Code : PED

Exclusivity Expiration Date : 2027-11-14

Application Number : 204026

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

POMALIDOMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-297

Exclusivity Expiration Date

2027-05-14

Application Number

204026

Product Number

4

Exclusivity Details

06

BRISTOL

Immuno-Oncology 360

Not Confirmed

BRISTOL

United Kingdom

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

POMALIDOMIDE

Exclusivity Code : ODE-297

Exclusivity Expiration Date : 2027-05-14

Application Number : 204026

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

POMALIDOMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-296

Exclusivity Expiration Date

2027-05-14

Application Number

204026

Product Number

4

Exclusivity Details

07

BRISTOL

Immuno-Oncology 360

Not Confirmed

BRISTOL

United Kingdom

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

POMALIDOMIDE

Exclusivity Code : ODE-296

Exclusivity Expiration Date : 2027-05-14

Application Number : 204026

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

POMALIDOMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-296

Exclusivity Expiration Date

2027-05-14

Application Number

204026

Product Number

3

Exclusivity Details

08

BRISTOL

Immuno-Oncology 360

Not Confirmed

BRISTOL

United Kingdom

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

POMALIDOMIDE

Exclusivity Code : ODE-296

Exclusivity Expiration Date : 2027-05-14

Application Number : 204026

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

POMALIDOMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-297

Exclusivity Expiration Date

2027-05-14

Application Number

204026

Product Number

3

Exclusivity Details

09

BRISTOL

Immuno-Oncology 360

Not Confirmed

BRISTOL

United Kingdom

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

POMALIDOMIDE

Exclusivity Code : ODE-297

Exclusivity Expiration Date : 2027-05-14

Application Number : 204026

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BRISTOL

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

POMALIDOMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-296

Exclusivity Expiration Date

2027-05-14

Application Number

204026

Product Number

2

Exclusivity Details

10

BRISTOL

Immuno-Oncology 360

Not Confirmed

BRISTOL

United Kingdom

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

POMALIDOMIDE

Exclusivity Code : ODE-296

Exclusivity Expiration Date : 2027-05-14

Application Number : 204026

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!